Related references
Note: Only part of the references are listed.Clinical predictors of mortality due to COVID-19 based on an analysis of data of 150 patients from Wuhan, China
Qiurong Ruan et al.
INTENSIVE CARE MEDICINE (2020)
Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China
Chaolin Huang et al.
LANCET (2020)
Clinical Characteristics of Coronavirus Disease 2019 in China
W. Guan et al.
NEW ENGLAND JOURNAL OF MEDICINE (2020)
The correlation between viral clearance and biochemical outcomes of 94 COVID-19 infected discharged patients
Jing Yuan et al.
INFLAMMATION RESEARCH (2020)
Cardiovascular Considerations in Treating Patients With Coronavirus Disease 2019 (COVID-19)
Dave L. Dixon et al.
JOURNAL OF CARDIOVASCULAR PHARMACOLOGY (2020)
Diagnostic utility of clinical laboratory data determinations for patients with the severe COVID-19
Yong Gao et al.
JOURNAL OF MEDICAL VIROLOGY (2020)
Risk Factors Associated With Acute Respiratory Distress Syndrome and Death in Patients With Coronavirus Disease 2019 Pneumonia in Wuhan, China
Chaomin Wu et al.
JAMA INTERNAL MEDICINE (2020)
Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study
Fei Zhou et al.
LANCET (2020)
COVID-19: consider cytokine storm syndromes and immunosuppression
Puja Mehta et al.
LANCET (2020)
Identification of a nerve-associated, lung-resident interstitial macrophage subset with distinct localization and immunoregulatory properties
Basak B. Ural et al.
SCIENCE IMMUNOLOGY (2020)
GM-CSF blockade with mavrilimumab in severe COVID-19 pneumonia and systemic hyperinflammation: a single-centre, prospective cohort study
Giacomo De Luca et al.
LANCET RHEUMATOLOGY (2020)
Interleukin-6: A Masterplayer in the Cytokine Network
Peter Uciechowski et al.
ONCOLOGY (2020)
Novel findings in neutrophil biology and their impact on cardiovascular disease
Aldo Bonaventura et al.
CARDIOVASCULAR RESEARCH (2019)
GM-CSF- and IRF4-Dependent Signaling Can Regulate Myeloid Cell Numbers and the Macrophage Phenotype during Inflammation
Ming-Chin Lee et al.
JOURNAL OF IMMUNOLOGY (2019)
Mavrilimumab: a unique insight and update on the current status in the treatment of rheumatoid arthritis
Chiara Crotti et al.
EXPERT OPINION ON INVESTIGATIONAL DRUGS (2019)
NLRP3 Inflammasome in Acute Myocardial Infarction
Adolfo G. Mauro et al.
JOURNAL OF CARDIOVASCULAR PHARMACOLOGY (2019)
The IL-1 family of cytokines and receptors in rheumatic diseases
Charles Anthony Dinarello
NATURE REVIEWS RHEUMATOLOGY (2019)
GM-CSF-Dependent Inflammatory Pathways
John A. Hamilton
FRONTIERS IN IMMUNOLOGY (2019)
GM-CSF inhibition reduces cytokine release syndrome and neuroinflammation but enhances CAR-T cell function in xenografts
Rosalie M. Sterner et al.
BLOOD (2019)
Pharmacodynamic biomarkers and differential effects of TNF- and GM-CSF-targeting biologics in rheumatoid arthritis
Xiang Guo et al.
INTERNATIONAL JOURNAL OF RHEUMATIC DISEASES (2019)
Efficacy and safety of namilumab, a human monoclonal antibody against granulocyte-macrophage colony-stimulating factor (GM-CSF) ligand in patients with rheumatoid arthritis (RA) with either an inadequate response to background methotrexate therapy or an inadequate response or intolerance to an anti-TNF (tumour necrosis factor) biologic therapy: a randomized, controlled trial
Peter C. Taylor et al.
ARTHRITIS RESEARCH & THERAPY (2019)
The NLRP3 inflammasome in acute myocardial infarction
Stefano Toldo et al.
NATURE REVIEWS CARDIOLOGY (2018)
Blockade of GM-CSF pathway induced sustained suppression of myeloid and T cell activities in rheumatoid arthritis
Xiang Guo et al.
RHEUMATOLOGY (2018)
A Randomized Phase IIb Study of Mavrilimumab and Golimumab in Rheumatoid Arthritis
Michael E. Weinblatt et al.
ARTHRITIS & RHEUMATOLOGY (2018)
Glucocorticoids promote apoptosis of proinflammatory monocytes by inhibiting ERK activity
Adrian Achuthan et al.
CELL DEATH & DISEASE (2018)
Pulmonary alveolar proteinosis in adults: pathophysiology and clinical approach
Anupam Kumar et al.
LANCET RESPIRATORY MEDICINE (2018)
The Pathogenic Involvement of Neutrophils in Acute Respiratory Distress Syndrome and Transfusion-Related Acute Lung Injury
Johan Rebetz et al.
TRANSFUSION MEDICINE AND HEMOTHERAPY (2018)
Alveolar Macrophages in the Resolution of Inflammation, Tissue Repair, and Tolerance to Infection
Benoit Allard et al.
FRONTIERS IN IMMUNOLOGY (2018)
The Two-Faced Cytokine IL-6 in Host Defense and Diseases
Masashi Narazaki et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2018)
Myocarditis Elicits Dendritic Cell and Monocyte Infiltration in the Heart and Self-Antigen Presentation by Conventional Type 2 Dendritic Cells
Katrien Van der Borght et al.
FRONTIERS IN IMMUNOLOGY (2018)
Cytokine release syndrome: Who is at risk and how to treat
Noelle Frey
BEST PRACTICE & RESEARCH CLINICAL HAEMATOLOGY (2017)
A randomised phase IIb study of mavrilimumab, a novel GM-CSF receptor alpha monoclonal antibody, in the treatment of rheumatoid arthritis
Gerd R. Burmester et al.
ANNALS OF THE RHEUMATIC DISEASES (2017)
MORAB-022, AN ANTI-GRANULOCYTE MACROPHAGE-COLONY STIMULATING FACTOR (GM-CSF) MONOCLONAL ANTIBODY (MAB): RESULTS OF THE FIRST STUDY IN PATIENTS WITH MILD-TO-MODERATE RHEUMATOID ARTHRITIS (RA)
A. Kivitz et al.
ANNALS OF THE RHEUMATIC DISEASES (2016)
Toxicities of chimeric antigen receptor T cells: recognition and management
Jennifer N. Brudno et al.
BLOOD (2016)
Interleukin-1 Receptor Blockade Is Associated With Reduced Mortality in Sepsis Patients With Features of Macrophage Activation Syndrome: Reanalysis of a Prior Phase III Trial
Bita Shakoory et al.
CRITICAL CARE MEDICINE (2016)
Targeting Inflammation in Primary Cardiovascular Prevention
Federico Carbone et al.
CURRENT PHARMACEUTICAL DESIGN (2016)
Granulocyte macrophage colony-stimulating factor induces CCL17 pro uction via IRF4 to mediate inflammation
Adrian Achuthan et al.
JOURNAL OF CLINICAL INVESTIGATION (2016)
Pulmonary pharmacodynamics of an anti-GM-CSFR antibody enables therapeutic dosing that limits exposure in the lung
Jamie Campbell et al.
MABS (2016)
Identification of Predictive Biomarkers for Cytokine Release Syndrome after Chimeric Antigen Receptor T-cell Therapy for Acute Lymphoblastic Leukemia
David T. Teachey et al.
CANCER DISCOVERY (2016)
IL-1β/IL-6/CRP and IL-18/ferritin: Distinct Inflammatory Programs in Infections
Jeroen Slaats et al.
PLOS PATHOGENS (2016)
Dual Role of GM-CSF as a Pro-Inflammatory and a Regulatory Cytokine: Implications for Immune Therapy
Palash Bhattacharya et al.
JOURNAL OF INTERFERON AND CYTOKINE RESEARCH (2015)
Pivotal Roles of GM-CSF in Autoimmunity and Inflammation
Aoi Shiomi et al.
MEDIATORS OF INFLAMMATION (2015)
Delivery of GM-CSF to Protect against Influenza Pneumonia
Renuka Subramaniam et al.
PLOS ONE (2015)
IL-1β and TNFα Promote Monocyte Viability through the Induction of GM-CSF Expression by Rheumatoid Arthritis Synovial Fibroblasts
Christelle Darrieutort-Laffite et al.
MEDIATORS OF INFLAMMATION (2014)
Control of T Helper 2 Responses by Transcription Factor IRF4-Dependent Dendritic Cells
Yan Gao et al.
IMMUNITY (2013)
Colony stimulating factors and myeloid cell biology in health and disease
John A. Hamilton et al.
TRENDS IN IMMUNOLOGY (2013)
A randomized trial of recombinant human granulocyte-macrophage colony stimulating factor for patients with acute lung injury
Robert Paine et al.
CRITICAL CARE MEDICINE (2012)
Inflammasome-Derived IL-1β Regulates the Production of GM-CSF by CD4+ T Cells and γδ T Cells
John R. Lukens et al.
JOURNAL OF IMMUNOLOGY (2012)
GM-CSF in the Lung Protects against Lethal Influenza Infection
Fang-Fang Huang et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2011)
A dual role for the immune response in a mouse model of inflammation-associated lung cancer
Michael Dougan et al.
JOURNAL OF CLINICAL INVESTIGATION (2011)
RORγt drives production of the cytokine GM-CSF in helper T cells, which is essential for the effector phase of autoimmune neuroinflammation
Laura Codarri et al.
NATURE IMMUNOLOGY (2011)
Hereditary Pulmonary Alveolar Proteinosis Pathogenesis, Presentation, Diagnosis, and Therapy
Takuji Suzuki et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2010)
Alternative modes of GM-CSF receptor activation revealed using activated mutants of the common β-subunit
Michelle Perugini et al.
BLOOD (2010)
GM-CSF mediates autoimmunity by enhancing IL-6-dependent Th17 cell development and survival
Ivo Sonderegger et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2008)
Alveolar macrophages are indispensable for controlling influenza viruses in lungs of pigs
Heui Man Kim et al.
JOURNAL OF VIROLOGY (2008)
Colony-stimulating factors in inflammation and autoimmunity
John A. Hamilton
NATURE REVIEWS IMMUNOLOGY (2008)
Granulocyte-macrophage colony-stimulating factor (GM-CSF) and T-cell responses: what we do and don't know
YF Shi et al.
CELL RESEARCH (2006)
Molgramostim (GM-CSF) associated with antibiotic treatment in nontraumatic abdominal sepsis -: A randomized, double-blind, placebo-controlled clinical trial
H Orozco et al.
ARCHIVES OF SURGERY (2006)
Pathogenicity of influenza viruses with genes from the 1918 pandemic virus:: Functional roles of alveolar macrophages and neutrophils in limiting virus replication and mortality in mice
TM Tumpey et al.
JOURNAL OF VIROLOGY (2005)
Differential expression of IFN regulatory factor 4 gene in human monocyte-derived dendritic cells and macrophages
A Lehtonen et al.
JOURNAL OF IMMUNOLOGY (2005)
Granulocyte-macrophage colony-stimulating factor gene-modified autologous tumor vaccines in non-small-cell lung cancer
J Nemunaitis et al.
JOURNAL OF THE NATIONAL CANCER INSTITUTE (2004)
Orally administered IL-6 induces elevated intestinal GM-CSF gene expression and splenic CFU-GM
FM Rollwagen et al.
CYTOKINE (2004)
Relationship of anti-GM-CSF antibody concentration, surfactant protein A and B levels, and serum LDH to pulmonary parameters and response to GM-CSF therapy in patients with idiopathic alveolar proteinosis
JF Seymour et al.
THORAX (2003)
A randomized phase II trial of granulocyte-macrophage colony-stimulating factor therapy in severe sepsis with respiratory dysfunction
JJ Presneill et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2002)
Fc receptor-mediated phagocytosis makes a significant contribution to clearance of influenza virus infections
VC Huber et al.
JOURNAL OF IMMUNOLOGY (2001)
G-CSF and IL-8 but not GM-CSF correlate with severity of pulmonary neutrophilia in acute respiratory distress syndrome
A Aggarwal et al.
EUROPEAN RESPIRATORY JOURNAL (2000)
Modulation of neutrophil apoptosis by granulocyte colony-stimulating factor and granulocyte/macrophage colony-stimulating factor during the course of acute respiratory distress syndrome
G Matute-Bello et al.
CRITICAL CARE MEDICINE (2000)
Share Paper
